{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:35:43Z","timestamp":1776432943753,"version":"3.51.2"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09066-x","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T20:49:38Z","timestamp":1749329378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recombinant BCG Expressing IL-12 as A Novel Immunomodulatory Strategy for Allergic Asthma: Opportunities and Challenges"],"prefix":"10.1007","volume":"68","author":[{"given":"Romina","family":"Campos-Povea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Gonz\u00e1lez-Madrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tays","family":"Troncoso-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hern\u00e1n F.","family":"Pe\u00f1aloza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"key":"9066_CR1","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/jpm12071162","volume":"12","author":"N Papapostolou","year":"2022","unstructured":"Papapostolou N, Makris M (2022) Allergic asthma in the era of personalized medicine. J Pers Med 12:1162. https:\/\/doi.org\/10.3390\/jpm12071162","journal-title":"J Pers Med"},{"key":"9066_CR2","doi-asserted-by":"publisher","first-page":"100995","DOI":"10.1016\/j.mam.2021.100995","volume":"85","author":"ZI Koml\u00f3si","year":"2022","unstructured":"Koml\u00f3si ZI, van de Veen W, Kov\u00e1cs N et al (2022) Cellular and molecular mechanisms of allergic asthma. Mol Asp Med 85:100995. https:\/\/doi.org\/10.1016\/j.mam.2021.100995","journal-title":"Mol Asp Med"},{"key":"9066_CR3","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2021.02.016","volume":"184","author":"H Hammad","year":"2021","unstructured":"Hammad H, Lambrecht BN (2021) The basic immunology of asthma. Cell 184:1469\u20131485. https:\/\/doi.org\/10.1016\/j.cell.2021.02.016","journal-title":"Cell"},{"key":"9066_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","volume":"50","author":"BN Lambrecht","year":"2019","unstructured":"Lambrecht BN, Hammad H, Fahy JV (2019) The Cytokines of Asthma. Immunity 50:975\u2013991. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.018","journal-title":"Immunity"},{"key":"9066_CR5","doi-asserted-by":"publisher","first-page":"1364774","DOI":"10.3389\/fimmu.2024.1364774","volume":"15","author":"C Guti\u00e9rrez-Vera","year":"2024","unstructured":"Guti\u00e9rrez-Vera C, Garc\u00eda-Betancourt R, Palacios PA et al (2024) Natural killer T cells in allergic asthma: implications for the development of novel immunotherapeutical strategies. Front Immunol 15:1364774. https:\/\/doi.org\/10.3389\/fimmu.2024.1364774","journal-title":"Front Immunol"},{"key":"9066_CR6","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1016\/j.vaccine.2021.07.092","volume":"39","author":"M Kowalewicz-Kulbat","year":"2021","unstructured":"Kowalewicz-Kulbat M, Locht C (2021) BCG for the prevention and treatment of allergic asthma. Vaccine 39:7341\u20137352. https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.092","journal-title":"Vaccine"},{"key":"9066_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrmicro1211","volume":"3","author":"P Andersen","year":"2005","unstructured":"Andersen P, Doherty TM (2005) The success and failure of BCG \u2014 implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3:656\u2013662. https:\/\/doi.org\/10.1038\/nrmicro1211","journal-title":"Nat Rev Microbiol"},{"key":"9066_CR8","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/s1473-3099(21)00403-5","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange C, Aaby P, Behr MA et al (2022) 100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin. Lancet Infect Dis 22:e2\u2013e12. https:\/\/doi.org\/10.1016\/s1473-3099(21)00403-5","journal-title":"Lancet Infect Dis"},{"key":"9066_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.coi.2014.06.003","volume":"29","author":"S Sakai","year":"2014","unstructured":"Sakai S, Mayer-Barber KD, Barber DL (2014) Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis. Curr Opin Immunol 29:137\u2013142. https:\/\/doi.org\/10.1016\/j.coi.2014.06.003","journal-title":"Curr Opin Immunol"},{"key":"9066_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/14760584.2017.1333906","volume":"16","author":"M Kowalewicz-Kulbat","year":"2017","unstructured":"Kowalewicz-Kulbat M, Locht C (2017) BCG and protection against inflammatory and auto-immune diseases. Expert Rev Vaccines 16:699\u2013708. https:\/\/doi.org\/10.1080\/14760584.2017.1333906","journal-title":"Expert Rev Vaccines"},{"key":"9066_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3390\/vaccines10050827","volume":"10","author":"M Kowalewicz-Kulbat","year":"2022","unstructured":"Kowalewicz-Kulbat M, Locht C (2022) Recombinant BCG to enhance its immunomodulatory activities. Vaccines 10:827. https:\/\/doi.org\/10.3390\/vaccines10050827","journal-title":"Vaccines"},{"key":"9066_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/ije\/dyp307","volume":"39","author":"M El-Zein","year":"2010","unstructured":"El-Zein M, Parent M-E, Benedetti A, Rousseau M-C (2010) Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies. Int J Epidemiology 39:469\u2013486. https:\/\/doi.org\/10.1093\/ije\/dyp307","journal-title":"Int J Epidemiology"},{"key":"9066_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jaci.2013.08.007","volume":"133","author":"MF Linehan","year":"2014","unstructured":"Linehan MF, Nurmatov U, Frank TL et al (2014) Does BCG vaccination protect against childhood asthma? Final results from the Manchester Community Asthma Study retrospective cohort study and updated systematic review and meta-analysis. J Allergy Clin Immunol 133:688-695.e14. https:\/\/doi.org\/10.1016\/j.jaci.2013.08.007","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/01.all.0000191238.20632.e2","volume":"5","author":"IB Barlan","year":"2005","unstructured":"Barlan IB, Bahceciler N, Akdis M, Akdis CA (2005) Role of bacillus Calmette-Gu\u00e9rin as an immunomodulator for the prevention and treatment of allergy and asthma. Curr Opin Allergy Clin Immunol 5:552\u2013557. https:\/\/doi.org\/10.1097\/01.all.0000191238.20632.e2","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9066_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1365-2567.1999.00782.x","volume":"97","author":"B Kumar","year":"1999","unstructured":"Kumar B, Matsuse, et al (1999) A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB\/c mice. Immunology 97:515\u2013521. https:\/\/doi.org\/10.1046\/j.1365-2567.1999.00782.x","journal-title":"Immunology"},{"key":"9066_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1165\/rcmb.2009-0040oc","volume":"43","author":"AP Christ","year":"2010","unstructured":"Christ AP, Rodriguez D, Bortolatto J et al (2010) Enhancement of Th1 lung immunity induced by recombinant Mycobacterium bovis bacillus Calmette-Guerin attenuates airway allergic disease. Am J Respir Cell Mol Biol 43:243\u2013252. https:\/\/doi.org\/10.1165\/rcmb.2009-0040oc","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9066_CR17","doi-asserted-by":"publisher","first-page":"20822","DOI":"10.1073\/pnas.0806244105","volume":"105","author":"SM Bueno","year":"2008","unstructured":"Bueno SM, Gonz\u00e1lez PA, Cautivo KM et al (2008) Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci 105:20822\u201320827. https:\/\/doi.org\/10.1073\/pnas.0806244105","journal-title":"Proc Natl Acad Sci"},{"key":"9066_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-0463.2011.02815.x","volume":"120","author":"C Lin","year":"2012","unstructured":"Lin C, Su I, Chang J et al (2012) Recombinant BCG coexpressing Ag85B, CFP10, and interleukin-12 induces multifunctional Th1 and memory T cells in mice. APMIS 120:72\u201382. https:\/\/doi.org\/10.1111\/j.1600-0463.2011.02815.x","journal-title":"APMIS"},{"key":"9066_CR19","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/vaccines11081304","volume":"11","author":"L Zhuang","year":"2023","unstructured":"Zhuang L, Ye Z, Li L et al (2023) Next-generation TB vaccines: progress, challenges, and prospects. Vaccines 11:1304. https:\/\/doi.org\/10.3390\/vaccines11081304","journal-title":"Vaccines"},{"key":"9066_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2500\/aap.2019.40.4253","volume":"40","author":"N Padem","year":"2019","unstructured":"Padem N, Saltoun C (2019) Classification of asthma. Allergy Asthma Proc 40:385\u2013388. https:\/\/doi.org\/10.2500\/aap.2019.40.4253","journal-title":"Allergy Asthma Proc"},{"key":"9066_CR21","doi-asserted-by":"publisher","first-page":"101333","DOI":"10.1016\/j.smim.2019.101333","volume":"46","author":"T Boonpiyathad","year":"2019","unstructured":"Boonpiyathad T, S\u00f6zener ZC, Satitsuksanoa P, Akdis CA (2019) Immunologic mechanisms in asthma. Semin Immunol 46:101333. https:\/\/doi.org\/10.1016\/j.smim.2019.101333","journal-title":"Semin Immunol"},{"key":"9066_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fped.2019.00246","volume":"7","author":"SC Dharmage","year":"2019","unstructured":"Dharmage SC, Perret JL, Custovic A (2019) Epidemiology of asthma in children and adults. Front Pediatr 7:246. https:\/\/doi.org\/10.3389\/fped.2019.00246","journal-title":"Front Pediatr"},{"key":"9066_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1471-2458-12-204","volume":"12","author":"T To","year":"2012","unstructured":"To T, Stanojevic S, Moores G et al (2012) Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Heal 12:204. https:\/\/doi.org\/10.1186\/1471-2458-12-204","journal-title":"BMC Public Heal"},{"key":"9066_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/35095579","volume":"1","author":"M Wills-Karp","year":"2001","unstructured":"Wills-Karp M, Santeliz J, Karp CL (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1:69\u201375. https:\/\/doi.org\/10.1038\/35095579","journal-title":"Nat Rev Immunol"},{"key":"9066_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11882-023-01089-8","volume":"23","author":"L Caraballo","year":"2023","unstructured":"Caraballo L, Llin\u00e1s-Caballero K (2023) The relationship of parasite allergens to allergic diseases. Curr Allergy Asthma Rep 23:363\u2013373. https:\/\/doi.org\/10.1007\/s11882-023-01089-8","journal-title":"Curr Allergy Asthma Rep"},{"key":"9066_CR26","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/all.15807","volume":"78","author":"YH Shin","year":"2023","unstructured":"Shin YH, Hwang J, Kwon R et al (2023) Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Allergy 78:2232\u20132254. https:\/\/doi.org\/10.1111\/all.15807","journal-title":"Allergy"},{"key":"9066_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12931-023-02475-6","volume":"24","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li Y, Gao Y et al (2023) Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respir Res 24:169. https:\/\/doi.org\/10.1186\/s12931-023-02475-6","journal-title":"Respir Res"},{"key":"9066_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/s0140-6736(20)31761-x","volume":"396","author":"JE Bennett","year":"2020","unstructured":"Bennett JE, Kontis V, Mathers CD et al (2020) NCD countdown 2030: pathways to achieving Sustainable Development Goal target 3.4. Lancet 396:918\u2013934. https:\/\/doi.org\/10.1016\/s0140-6736(20)31761-x","journal-title":"Lancet"},{"key":"9066_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jaip.2014.09.007","volume":"2","author":"P-PW Hekking","year":"2014","unstructured":"Hekking P-PW, Bel EH (2014) Developing and emerging clinical asthma phenotypes. J Allergy Clin Immunol: Pr 2:671\u2013680. https:\/\/doi.org\/10.1016\/j.jaip.2014.09.007","journal-title":"J Allergy Clin Immunol: Pr"},{"key":"9066_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","volume":"56","author":"ME Kuruvilla","year":"2019","unstructured":"Kuruvilla ME, Lee FE-H, Lee GB (2019) Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol 56:219\u2013233. https:\/\/doi.org\/10.1007\/s12016-018-8712-1","journal-title":"Clin Rev Allergy Immunol"},{"key":"9066_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaci.2003.10.041","volume":"113","author":"C Miranda","year":"2004","unstructured":"Miranda C, Busacker A, Balzar S et al (2004) Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 113:101\u2013108. https:\/\/doi.org\/10.1016\/j.jaci.2003.10.041","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR32","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.3390\/jcm12185856","volume":"12","author":"J Torres-Borrego","year":"2023","unstructured":"Torres-Borrego J, S\u00e1nchez-Sol\u00eds M (2023) Dissecting airborne allergens. J. Clin Med 12:5856. https:\/\/doi.org\/10.3390\/jcm12185856","journal-title":"Clin Med"},{"key":"9066_CR33","doi-asserted-by":"publisher","first-page":"637948","DOI":"10.3389\/fimmu.2021.637948","volume":"12","author":"B Le\u00f3n","year":"2021","unstructured":"Le\u00f3n B, Ballesteros-Tato A (2021) Modulating Th2 cell immunity for the treatment of asthma. Front Immunol 12:637948. https:\/\/doi.org\/10.3389\/fimmu.2021.637948","journal-title":"Front Immunol"},{"key":"9066_CR34","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.3390\/jcm11216567","volume":"11","author":"A Klain","year":"2022","unstructured":"Klain A, Dinardo G, Salvatori A et al (2022) An overview on the primary factors that contribute to non-allergic asthma in children. J Clin Med 11:6567. https:\/\/doi.org\/10.3390\/jcm11216567","journal-title":"J Clin Med"},{"key":"9066_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.taap.2013.07.010","volume":"272","author":"M He","year":"2013","unstructured":"He M, Ichinose T, Song Y et al (2013) Effects of two Asian sand dusts transported from the dust source regions of Inner Mongolia and northeast China on murine lung eosinophilia. Toxicol Appl Pharmacol 272:647\u2013655. https:\/\/doi.org\/10.1016\/j.taap.2013.07.010","journal-title":"Toxicol Appl Pharmacol"},{"key":"9066_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2500\/aap.2019.40.4261","volume":"40","author":"DK Lei","year":"2019","unstructured":"Lei DK, Grammer LC (2019) Occupational immunologic lung disease. Allergy Asthma Proc 40:418\u2013420. https:\/\/doi.org\/10.2500\/aap.2019.40.4261","journal-title":"Allergy Asthma Proc"},{"key":"9066_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1056\/nejmcibr1514013","volume":"374","author":"TM Laidlaw","year":"2016","unstructured":"Laidlaw TM, Boyce JA (2016) Aspirin-exacerbated respiratory disease \u2014 new prime suspects. N Engl J Med 374:484\u2013488. https:\/\/doi.org\/10.1056\/nejmcibr1514013","journal-title":"N Engl J Med"},{"key":"9066_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/s1081-1206(10)61948-5","volume":"89","author":"RA Tan","year":"2002","unstructured":"Tan RA, Spector SL (2002) Exercise-induced asthma: diagnosis and management. Ann Allergy, Asthma Immunol 89:226\u2013236. https:\/\/doi.org\/10.1016\/s1081-1206(10)61948-5","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"9066_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00408-011-9348-6","volume":"190","author":"MD Lougheed","year":"2012","unstructured":"Lougheed MD, Turcotte SE, Fisher T (2012) Cough variant asthma: lessons learned from deep inspirations. Lung 190:17\u201322. https:\/\/doi.org\/10.1007\/s00408-011-9348-6","journal-title":"Lung"},{"key":"9066_CR40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221094","volume":"220","author":"JA Harker","year":"2023","unstructured":"Harker JA, Lloyd CM (2023) T helper 2 cells in asthma. J Exp Med 220:e20221094. https:\/\/doi.org\/10.1084\/jem.20221094","journal-title":"J Exp Med"},{"key":"9066_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nm.2755","volume":"18","author":"SJ Galli","year":"2012","unstructured":"Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18:693\u2013704. https:\/\/doi.org\/10.1038\/nm.2755","journal-title":"Nat Med"},{"key":"9066_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1710-1492-10-10","volume":"10","author":"B Liu","year":"2014","unstructured":"Liu B, Ichinose T, He M et al (2014) Lung inflammation by fungus, Bjerkandera adusta isolated from Asian sand dust (ASD) aerosol and enhancement of ovalbumin-induced lung eosinophilia by ASD and the fungus in mice. Allergy, Asthma Clin Immunol 10:10. https:\/\/doi.org\/10.1186\/1710-1492-10-10","journal-title":"Allergy, Asthma Clin Immunol"},{"key":"9066_CR43","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/jat.3759","volume":"39","author":"K Sadakane","year":"2019","unstructured":"Sadakane K, Ichinose T, Nishikawa M (2019) Effects of co-exposure of lipopolysaccharide and \u03b2-glucan (Zymosan A) in exacerbating murine allergic asthma associated with Asian sand dust. J Appl Toxicol 39:672\u2013684. https:\/\/doi.org\/10.1002\/jat.3759","journal-title":"J Appl Toxicol"},{"key":"9066_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13223-016-0153-x","volume":"12","author":"K Sadakane","year":"2016","unstructured":"Sadakane K, Ichinose T, Nishikawa M et al (2016) Co-exposure to zymosan A and heat-inactivated Asian sand dust exacerbates ovalbumin-induced murine lung eosinophilia. Allergy, Asthma Clin Immunol 12:48. https:\/\/doi.org\/10.1186\/s13223-016-0153-x","journal-title":"Allergy, Asthma Clin Immunol"},{"key":"9066_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","volume":"15","author":"JV Fahy","year":"2015","unstructured":"Fahy JV (2015) Type 2 inflammation in asthma \u2014 present in most, absent in many. Nat Rev Immunol 15:57\u201365. https:\/\/doi.org\/10.1038\/nri3786","journal-title":"Nat Rev Immunol"},{"key":"9066_CR46","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jaci.2023.03.023","volume":"152","author":"WE LeSuer","year":"2023","unstructured":"LeSuer WE, Kienzl M, Ochkur SI et al (2023) Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice. J Allergy Clin Immunol 152:469-485.e10. https:\/\/doi.org\/10.1016\/j.jaci.2023.03.023","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-024-09012-3","volume":"68","author":"M Berkinbayeva","year":"2025","unstructured":"Berkinbayeva M, Gu W, Chen Z, Gao P (2025) Group 3 innate lymphoid cells: a potential therapeutic target for steroid resistant asthma. Clin Rev Allergy Immunol 68:1. https:\/\/doi.org\/10.1007\/s12016-024-09012-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"9066_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1164\/rccm.201611-2232pp","volume":"197","author":"TF Carr","year":"2017","unstructured":"Carr TF, Zeki AA, Kraft M (2017) Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med 197:22\u201337. https:\/\/doi.org\/10.1164\/rccm.201611-2232pp","journal-title":"Am J Respir Crit Care Med"},{"key":"9066_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24966\/adt-749x\/100014","volume":"6","author":"DOCAPS Italy Universit\u00e0 Cattolica Del Sacro Cuore, Rome, Boccabella C","year":"2023","unstructured":"DOCAPS Italy Universit\u00e0 Cattolica Del Sacro Cuore, Rome, Boccabella C (2023) Bronchial hyperreactivity (BHR): an old but gold hallmark of asthma. Allergy Disord Ther 6:1\u20138. https:\/\/doi.org\/10.24966\/adt-749x\/100014","journal-title":"Allergy Disord Ther"},{"key":"9066_CR50","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/cea.12506","volume":"45","author":"DG Chapman","year":"2015","unstructured":"Chapman DG, Irvin CG (2015) Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come. Clin Exp Allergy 45:706\u2013719. https:\/\/doi.org\/10.1111\/cea.12506","journal-title":"Clin Exp Allergy"},{"key":"9066_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/nejm200101043440106","volume":"344","author":"AB Kay","year":"2001","unstructured":"Kay AB (2001) Allergy and allergic diseases. N Engl J Med 344:30\u201337. https:\/\/doi.org\/10.1056\/nejm200101043440106","journal-title":"N Engl J Med"},{"key":"9066_CR52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11882-014-0465-1","volume":"14","author":"Y Yoo","year":"2014","unstructured":"Yoo Y, Perzanowski MS (2014) Allergic sensitization and the environment: latest update. Curr Allergy Asthma Rep 14:465. https:\/\/doi.org\/10.1007\/s11882-014-0465-1","journal-title":"Curr Allergy Asthma Rep"},{"key":"9066_CR53","doi-asserted-by":"publisher","first-page":"975914","DOI":"10.3389\/fimmu.2022.975914","volume":"13","author":"M Duchesne","year":"2022","unstructured":"Duchesne M, Okoye I, Lacy P (2022) Epithelial cell alarmin cytokines: frontline mediators of the asthma inflammatory response. Front Immunol 13:975914. https:\/\/doi.org\/10.3389\/fimmu.2022.975914","journal-title":"Front Immunol"},{"key":"9066_CR54","doi-asserted-by":"publisher","first-page":"1378877","DOI":"10.3389\/falgy.2024.1378877","volume":"5","author":"M Paolucci","year":"2024","unstructured":"Paolucci M, Antz N, Hom\u00e8re V et al (2024) A murine model of peanut-allergic asthma. Front Allergy 5:1378877. https:\/\/doi.org\/10.3389\/falgy.2024.1378877","journal-title":"Front Allergy"},{"key":"9066_CR55","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/thoraxjnl-2011-200606","volume":"67","author":"S Post","year":"2012","unstructured":"Post S, Nawijn MC, Hackett TL et al (2012) The composition of house dust mite is critical for mucosal barrier dysfunction and allergic sensitisation. Thorax 67:488. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200606","journal-title":"Thorax"},{"key":"9066_CR56","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00281-012-0334-8","volume":"34","author":"B Ruiter","year":"2012","unstructured":"Ruiter B, Shreffler WG (2012) Innate immunostimulatory properties of allergens and their relevance to food allergy. Semin Immunopathol 34:617\u2013632. https:\/\/doi.org\/10.1007\/s00281-012-0334-8","journal-title":"Semin Immunopathol"},{"key":"9066_CR57","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","volume":"24","author":"GM Gauvreau","year":"2020","unstructured":"Gauvreau GM, Sehmi R, Ambrose CS, Griffiths JM (2020) Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Expert Opin Ther Targets 24:777\u2013792. https:\/\/doi.org\/10.1080\/14728222.2020.1783242","journal-title":"Expert Opin Ther Targets"},{"key":"9066_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.immunol.25.022106.141718","volume":"25","author":"Y-J Liu","year":"2007","unstructured":"Liu Y-J, Soumelis V, Watanabe N et al (2007) TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 25:193\u2013219. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141718","journal-title":"Annu Rev Immunol"},{"key":"9066_CR59","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.4049\/jimmunol.160.8.4090","volume":"160","author":"BN Lambrecht","year":"1998","unstructured":"Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA (1998) Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160:4090\u20134097. https:\/\/doi.org\/10.4049\/jimmunol.160.8.4090","journal-title":"J Immunol"},{"key":"9066_CR60","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jcp.54.8.577","volume":"54","author":"J-C Renauld","year":"2001","unstructured":"Renauld J-C (2001) New insights into the role of cytokines in asthma. J Clin Pathol 54:577. https:\/\/doi.org\/10.1136\/jcp.54.8.577","journal-title":"J Clin Pathol"},{"key":"9066_CR61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1165\/ajrcmb.26.2.4600","volume":"26","author":"R Venkayya","year":"2002","unstructured":"Venkayya R, Lam M, Willkom M et al (2002) The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 26:202\u2013208. https:\/\/doi.org\/10.1165\/ajrcmb.26.2.4600","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9066_CR62","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3389\/fphys.2019.01514","volume":"10","author":"C Pelaia","year":"2019","unstructured":"Pelaia C, Paoletti G, Puggioni F et al (2019) Interleukin-5 in the pathophysiology of severe asthma. Front Physiol 10:1514. https:\/\/doi.org\/10.3389\/fphys.2019.01514","journal-title":"Front Physiol"},{"key":"9066_CR63","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1365-2222.2008.03000.x","volume":"38","author":"A Edwards","year":"2008","unstructured":"Edwards A (2008) The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy 38:1063\u20131064. https:\/\/doi.org\/10.1111\/j.1365-2222.2008.03000.x","journal-title":"Clin Exp Allergy"},{"key":"9066_CR64","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2500\/aap.2019.40.4274","volume":"40","author":"MC Dispenza","year":"2019","unstructured":"Dispenza MC (2019) Classification of hypersensitivity reactions. Allergy Asthma Proc 40:470\u2013473. https:\/\/doi.org\/10.2500\/aap.2019.40.4274","journal-title":"Allergy Asthma Proc"},{"key":"9066_CR65","doi-asserted-by":"publisher","first-page":"32883","DOI":"10.1074\/jbc.r110.197046","volume":"286","author":"AB Mukherjee","year":"2011","unstructured":"Mukherjee AB, Zhang Z (2011) Allergic asthma: influence of genetic and environmental factors. J Biol Chem 286:32883\u201332889. https:\/\/doi.org\/10.1074\/jbc.r110.197046","journal-title":"J Biol Chem"},{"key":"9066_CR66","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1080\/21655979.2022.2044278","volume":"13","author":"GH Banafea","year":"2022","unstructured":"Banafea GH, Bakhashab S, Alshaibi HF et al (2022) The role of human mast cells in allergy and asthma. Bioengineered 13:7049\u20137064. https:\/\/doi.org\/10.1080\/21655979.2022.2044278","journal-title":"Bioengineered"},{"key":"9066_CR67","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00441-016-2566-8","volume":"367","author":"H Fehrenbach","year":"2017","unstructured":"Fehrenbach H, Wagner C, Wegmann M (2017) Airway remodeling in asthma: what really matters. Cell Tissue Res 367:551\u2013569. https:\/\/doi.org\/10.1007\/s00441-016-2566-8","journal-title":"Cell Tissue Res"},{"key":"9066_CR68","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1365-2222.2008.02971.x","volume":"38","author":"Holgate ST","year":"2008","unstructured":"Holgate ST (2008) Pathogenesis of asthma. Clin Exp Allergy 38:872\u2013897. https:\/\/doi.org\/10.1111\/j.1365-2222.2008.02971.x","journal-title":"Clin Exp Allergy"},{"key":"9066_CR69","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/ph3030514","volume":"3","author":"PJ Barnes","year":"2010","unstructured":"Barnes PJ (2010) Inhaled corticosteroids. Pharmaceuticals 3:514\u2013540. https:\/\/doi.org\/10.3390\/ph3030514","journal-title":"Pharmaceuticals"},{"key":"9066_CR70","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","volume":"131","author":"PJ Barnes","year":"2013","unstructured":"Barnes PJ (2013) Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 131:636\u2013645. https:\/\/doi.org\/10.1016\/j.jaci.2012.12.1564","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaci.2013.10.053","volume":"133","author":"R Beasley","year":"2014","unstructured":"Beasley R, Weatherall M, Shirtcliffe P et al (2014) Combination corticosteroid\/\u03b2-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma? J Allergy Clin Immunol 133:39\u201341. https:\/\/doi.org\/10.1016\/j.jaci.2013.10.053","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR72","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1164\/rccm.201209-1739pp","volume":"187","author":"M Cazzola","year":"2013","unstructured":"Cazzola M, Page CP, Rogliani P, Matera MG (2013) \u03b22-agonist therapy in lung disease. Am J Respir Crit Care Med 187:690\u2013696. https:\/\/doi.org\/10.1164\/rccm.201209-1739pp","journal-title":"Am J Respir Crit Care Med"},{"key":"9066_CR73","doi-asserted-by":"publisher","first-page":"S322","DOI":"10.1067\/mai.2002.129966","volume":"110","author":"MR Sears","year":"2002","unstructured":"Sears MR (2002) Adverse effects of \u03b2-agonists. J Allergy Clin Immunol 110:S322\u2013S328. https:\/\/doi.org\/10.1067\/mai.2002.129966","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4168\/aair.2024.16.3.217","volume":"16","author":"DI Suh","year":"2024","unstructured":"Suh DI, Johnston SL (2024) The wiser strategy of using beta-agonists in asthma: mechanisms and rationales. Allergy Asthma Immunol Res 16:217\u2013234. https:\/\/doi.org\/10.4168\/aair.2024.16.3.217","journal-title":"Allergy Asthma Immunol Res"},{"key":"9066_CR75","doi-asserted-by":"publisher","first-page":"CD002314","DOI":"10.1002\/14651858.cd002314.pub3","volume":"2014","author":"BF Chauhan","year":"2012","unstructured":"Chauhan BF, Ducharme FM (2012) Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and\/or chronic asthma in adults and children. Cochr Database Syst Rev 2014:CD002314. https:\/\/doi.org\/10.1002\/14651858.cd002314.pub3","journal-title":"Cochr Database Syst Rev"},{"key":"9066_CR76","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2165\/00002018-200730050-00005","volume":"30","author":"BR Twaites","year":"2007","unstructured":"Twaites BR, Wilton LV, Shakir SAW (2007) Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England. Drug Saf 30:419\u2013429. https:\/\/doi.org\/10.2165\/00002018-200730050-00005","journal-title":"Drug Saf"},{"key":"9066_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/164_2021_483","volume":"268","author":"NG Papadopoulos","year":"2021","unstructured":"Papadopoulos NG, Miligkos M, Xepapadaki P (2021) Allergic diseases \u2013 from basic mechanisms to comprehensive management and prevention. Handb Exp Pharmacol 268:69\u201393. https:\/\/doi.org\/10.1007\/164_2021_483","journal-title":"Handb Exp Pharmacol"},{"key":"9066_CR78","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1034\/j.1398-9995.57.s72.2.x","volume":"57","author":"G Balzano","year":"2002","unstructured":"Balzano G, Fuschillo S, Gaudiosi C (2002) Leukotriene receptor antagonists in the treatment of asthma: an update. Allergy 57:16\u201319. https:\/\/doi.org\/10.1034\/j.1398-9995.57.s72.2.x","journal-title":"Allergy"},{"key":"9066_CR79","doi-asserted-by":"publisher","first-page":"2102467","DOI":"10.1183\/13993003.02467-2021","volume":"60","author":"JS Park","year":"2022","unstructured":"Park JS, Cho YJ, Yun J-Y et al (2022) Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series. Eur Respir J 60:2102467. https:\/\/doi.org\/10.1183\/13993003.02467-2021","journal-title":"Eur Respir J"},{"key":"9066_CR80","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/164_2016_72","volume":"237","author":"T Tamada","year":"2016","unstructured":"Tamada T, Ichinose M (2016) Pharmacology and therapeutics of asthma and COPD. Handb Exp Pharmacol 237:153\u2013169. https:\/\/doi.org\/10.1007\/164_2016_72","journal-title":"Handb Exp Pharmacol"},{"key":"9066_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/5584_2016_29","volume":"935","author":"R Rubinsztajn","year":"2016","unstructured":"Rubinsztajn R, Chazan R (2016) Pulmonary Infection and Inflammation. Adv Exp Med Biol 935:35\u201342. https:\/\/doi.org\/10.1007\/5584_2016_29","journal-title":"Adv Exp Med Biol"},{"key":"9066_CR82","doi-asserted-by":"publisher","first-page":"100787","DOI":"10.1016\/j.waojou.2023.100787","volume":"16","author":"F Menzella","year":"2023","unstructured":"Menzella F, Just J, Sauerbeck IS et al (2023) Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU\/mL. World Allergy Organ J 16:100787. https:\/\/doi.org\/10.1016\/j.waojou.2023.100787","journal-title":"World Allergy Organ J"},{"key":"9066_CR83","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jaip.2014.03.010","volume":"2","author":"M Humbert","year":"2014","unstructured":"Humbert M, Busse W, Hanania NA et al (2014) Omalizumab in asthma: an update on recent developments. J Allergy Clin Immunol: Pr 2:525-536.e1. https:\/\/doi.org\/10.1016\/j.jaip.2014.03.010","journal-title":"J Allergy Clin Immunol: Pr"},{"key":"9066_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/jaa.s29811","volume":"5","author":"AK Ali","year":"2012","unstructured":"Ali AK, Hartzema AG (2012) Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting. J Asthma Allergy 5:1\u20139. https:\/\/doi.org\/10.2147\/jaa.s29811","journal-title":"J Asthma Allergy"},{"key":"9066_CR85","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/nejmoa1403290","volume":"371","author":"HG Ortega","year":"2014","unstructured":"Ortega HG, Liu MC, Pavord ID et al (2014) Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371:1198\u20131207. https:\/\/doi.org\/10.1056\/nejmoa1403290","journal-title":"N Engl J Med"},{"key":"9066_CR86","doi-asserted-by":"publisher","first-page":"1320458","DOI":"10.3389\/fphar.2023.1320458","volume":"14","author":"F Zou","year":"2023","unstructured":"Zou F, Zhu C, Lou S et al (2023) A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database. Front Pharmacol 14:1320458. https:\/\/doi.org\/10.3389\/fphar.2023.1320458","journal-title":"Front Pharmacol"},{"key":"9066_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40413-015-0063-2","volume":"8","author":"CA Akdis","year":"2015","unstructured":"Akdis CA, Akdis M (2015) Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J 8:1\u201312. https:\/\/doi.org\/10.1186\/s40413-015-0063-2","journal-title":"World Allergy Organ J"},{"key":"9066_CR88","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12948-018-0085-8","volume":"16","author":"M Ferrando","year":"2018","unstructured":"Ferrando M, Racca F, Madeira LNG et al (2018) A critical appraisal on AIT in childhood asthma. Clin Mol Allergy 16:6. https:\/\/doi.org\/10.1186\/s12948-018-0085-8","journal-title":"Clin Mol Allergy"},{"key":"9066_CR89","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/all.12638","volume":"70","author":"C Pitsios","year":"2015","unstructured":"Pitsios C, Demoly P, Bil\u00f2 MB et al (2015) Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy 70:897\u2013909. https:\/\/doi.org\/10.1111\/all.12638","journal-title":"Allergy"},{"key":"9066_CR90","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1056\/nejm199602223340811","volume":"334","author":"PJ Barnes","year":"1996","unstructured":"Barnes PJ (1996) Is immunotherapy for asthma worthwhile? N Engl J Med 334:531\u2013532. https:\/\/doi.org\/10.1056\/nejm199602223340811","journal-title":"N Engl J Med"},{"key":"9066_CR91","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","volume":"157","author":"P Chames","year":"2009","unstructured":"Chames P, Regenmortel MV, Weiss E, Baty D (2009) Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 157:220\u2013233. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00190.x","journal-title":"Br J Pharmacol"},{"key":"9066_CR92","doi-asserted-by":"publisher","first-page":"101483","DOI":"10.1016\/j.disamonth.2022.101483","volume":"69","author":"VH Patel","year":"2023","unstructured":"Patel VH, Thannir S, Dhanani M et al (2023) Current limitations and recent advances in the management of asthma. Dis-a-Mon 69:101483. https:\/\/doi.org\/10.1016\/j.disamonth.2022.101483","journal-title":"Dis-a-Mon"},{"key":"9066_CR93","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/bph.13396","volume":"173","author":"N Landolina","year":"2016","unstructured":"Landolina N, Levi-Schaffer F (2016) Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17. Br J Pharmacol 173:793\u2013803. https:\/\/doi.org\/10.1111\/bph.13396","journal-title":"Br J Pharmacol"},{"key":"9066_CR94","doi-asserted-by":"publisher","first-page":"243ra85","DOI":"10.1126\/scitranslmed.3008961","volume":"6","author":"GM Gauvreau","year":"2014","unstructured":"Gauvreau GM, Harris JM, Boulet L-P et al (2014) Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production. Sci Transl Med 6:243ra85. https:\/\/doi.org\/10.1126\/scitranslmed.3008961","journal-title":"Sci Transl Med"},{"key":"9066_CR95","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/cea.12400","volume":"44","author":"JP Arm","year":"2014","unstructured":"Arm JP, Bottoli I, Skerjanec A et al (2014) Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects. Clin Exp Allergy 44:1371\u20131385. https:\/\/doi.org\/10.1111\/cea.12400","journal-title":"Clin Exp Allergy"},{"key":"9066_CR96","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.jaci.2016.06.023","volume":"138","author":"JM Harris","year":"2016","unstructured":"Harris JM, Cabanski CR, Scheerens H et al (2016) A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria. J Allergy Clin Immunol 138:1730\u20131732. https:\/\/doi.org\/10.1016\/j.jaci.2016.06.023","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR97","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1164\/rccm.201208-1414oc","volume":"187","author":"NA Hanania","year":"2013","unstructured":"Hanania NA, Wenzel S, Ros\u00e9n K et al (2013) Exploring the effects of omalizumab in allergic asthma. Am J Respir Crit Care Med 187:804\u2013811. https:\/\/doi.org\/10.1164\/rccm.201208-1414oc","journal-title":"Am J Respir Crit Care Med"},{"key":"9066_CR98","doi-asserted-by":"publisher","first-page":"CD003559","DOI":"10.1002\/14651858.cd003559.pub4","volume":"2014","author":"R Normansell","year":"2014","unstructured":"Normansell R, Walker S, Milan SJ et al (2014) Omalizumab for asthma in adults and children. Cochrane Database Syst Rev 2014:CD003559. https:\/\/doi.org\/10.1002\/14651858.cd003559.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"9066_CR99","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/imr.13380","volume":"328","author":"A Eggel","year":"2024","unstructured":"Eggel A, Pennington LF, Jardetzky TS (2024) Therapeutic monoclonal antibodies in allergy: targeting IgE, cytokine, and alarmin pathways. Immunol Rev 328:387\u2013411. https:\/\/doi.org\/10.1111\/imr.13380","journal-title":"Immunol Rev"},{"key":"9066_CR100","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s2213-2600(15)00042-9","volume":"3","author":"M Castro","year":"2015","unstructured":"Castro M, Zangrilli J, Wechsler ME et al (2015) Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med 3:355\u2013366. https:\/\/doi.org\/10.1016\/s2213-2600(15)00042-9","journal-title":"Lancet Respir Med"},{"key":"9066_CR101","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/s0140-6736(16)31324-1","volume":"388","author":"ER Bleecker","year":"2016","unstructured":"Bleecker ER, FitzGerald JM, Chanez P et al (2016) Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet 388:2115\u20132127. https:\/\/doi.org\/10.1016\/s0140-6736(16)31324-1","journal-title":"Lancet"},{"key":"9066_CR102","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/nejmoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID et al (2018) Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378:2486\u20132496. https:\/\/doi.org\/10.1056\/nejmoa1804092","journal-title":"N Engl J Med"},{"key":"9066_CR103","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.arbres.2014.02.002","volume":"50","author":"S Quirce","year":"2014","unstructured":"Quirce S, Bobolea I, Dom\u00ednguez-Ortega J, Barranco P (2014) Futuras terapias biol\u00f3gicas en el asma. Arch Bronconeumol 50:355\u2013361. https:\/\/doi.org\/10.1016\/j.arbres.2014.02.002","journal-title":"Arch Bronconeumol"},{"key":"9066_CR104","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1111\/all.15054","volume":"76","author":"I Agache","year":"2021","unstructured":"Agache I, Eguiluz-Gracia I, Cojanu C et al (2021) Advances and highlights in asthma in 2021. Allergy 76:3390\u20133407. https:\/\/doi.org\/10.1111\/all.15054","journal-title":"Allergy"},{"key":"9066_CR105","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43556-024-00210-1","volume":"5","author":"H Aboul-Ella","year":"2024","unstructured":"Aboul-Ella H, Gohar A, Ali AA et al (2024) Monoclonal antibodies: from magic bullet to precision weapon. Mol Biomed 5:47. https:\/\/doi.org\/10.1186\/s43556-024-00210-1","journal-title":"Mol Biomed"},{"key":"9066_CR106","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.alit.2020.08.002","volume":"69","author":"UC Kucuksezer","year":"2020","unstructured":"Kucuksezer UC, Ozdemir C, Cevhertas L et al (2020) Mechanisms of allergen-specific immunotherapy and allergen tolerance. Allergol Int 69:549\u2013560. https:\/\/doi.org\/10.1016\/j.alit.2020.08.002","journal-title":"Allergol Int"},{"key":"9066_CR107","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1067\/mai.2002.121317","volume":"109","author":"C M\u00f6ller","year":"2002","unstructured":"M\u00f6ller C, Dreborg S, Ferdousi HA et al (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 109:251\u2013256. https:\/\/doi.org\/10.1067\/mai.2002.121317","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR108","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/aci.0b013e3282f3b5cb","volume":"8","author":"SM Warner","year":"2008","unstructured":"Warner SM, Knight DA (2008) Airway modeling and remodeling in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol 8:44\u201348. https:\/\/doi.org\/10.1097\/aci.0b013e3282f3b5cb","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9066_CR109","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/pharmaceutics12090848","volume":"12","author":"J Watt","year":"2020","unstructured":"Watt J, Liu J (2020) Preclinical progress of subunit and live attenuated Mycobacterium tuberculosis vaccines: a review following the first in human efficacy trial. Pharmaceutics 12:848. https:\/\/doi.org\/10.3390\/pharmaceutics12090848","journal-title":"Pharmaceutics"},{"key":"9066_CR110","doi-asserted-by":"publisher","first-page":"101947","DOI":"10.1016\/j.tube.2020.101947","volume":"131","author":"MR Bright","year":"2021","unstructured":"Bright MR, Curtis N, Messina NL (2021) The role of antibodies in Bacille Calmette Gu\u00e9rin-mediated immune responses and protection against tuberculosis in humans: a systematic review. Tuberculosis 131:101947. https:\/\/doi.org\/10.1016\/j.tube.2020.101947","journal-title":"Tuberculosis"},{"key":"9066_CR111","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4161\/hv.5.2.7210","volume":"5","author":"J Liu","year":"2009","unstructured":"Liu J, Tran V, Leung AS et al (2009) BCG Vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccines 5:70\u201378. https:\/\/doi.org\/10.4161\/hv.5.2.7210","journal-title":"Hum Vaccines"},{"key":"9066_CR112","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1080\/21645515.2021.1885280","volume":"17","author":"T Cho","year":"2021","unstructured":"Cho T, Khatchadourian C, Nguyen H et al (2021) A review of the BCG vaccine and other approaches toward tuberculosis eradication. Hum Vaccines Immunother 17:2454\u20132470. https:\/\/doi.org\/10.1080\/21645515.2021.1885280","journal-title":"Hum Vaccines Immunother"},{"key":"9066_CR113","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","volume":"36","author":"T Cernuschi","year":"2018","unstructured":"Cernuschi T, Malvolti S, Nickels E, Friede M (2018) Bacillus Calmette-Gu\u00e9rin (BCG) vaccine: a global assessment of demand and supply balance. Vaccine 36:498\u2013506. https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.010","journal-title":"Vaccine"},{"key":"9066_CR114","doi-asserted-by":"publisher","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","volume":"168","author":"MOC Ota","year":"2002","unstructured":"Ota MOC, Vekemans J, Schlegel-Haueter SE et al (2002) Influence of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin on antibody and cytokine responses to human neonatal vaccination. J Immunol 168:919\u2013925. https:\/\/doi.org\/10.4049\/jimmunol.168.2.919","journal-title":"J Immunol"},{"key":"9066_CR115","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1128\/cvi.00162-15","volume":"22","author":"MC Boer","year":"2015","unstructured":"Boer MC, Prins C, van Meijgaarden KE et al (2015) Mycobacterium bovis BCG vaccination induces divergent proinflammatory or regulatory T cell responses in adults. Clin vaccine Immunol\u202f: CVI 22:778\u2013788. https:\/\/doi.org\/10.1128\/cvi.00162-15","journal-title":"Clin vaccine Immunol : CVI"},{"key":"9066_CR116","doi-asserted-by":"publisher","first-page":"102320","DOI":"10.1016\/j.tube.2023.102320","volume":"139","author":"NP Kumar","year":"2023","unstructured":"Kumar NP, Padmapriyadarsini C, Rajamanickam A et al (2023) BCG vaccination induces enhanced humoral responses in elderly individuals. Tuberculosis 139:102320. https:\/\/doi.org\/10.1016\/j.tube.2023.102320","journal-title":"Tuberculosis"},{"key":"9066_CR117","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen J, Gao L, Wu X et al (2023) BCG-induced trained immunity: history, mechanisms and potential applications. J Transl Med 21:106. https:\/\/doi.org\/10.1186\/s12967-023-03944-8","journal-title":"J Transl Med"},{"key":"9066_CR118","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4049\/jimmunol.1200061","volume":"190","author":"AM Green","year":"2013","unstructured":"Green AM, DiFazio R, Flynn JL (2013) IFN-\u03b3 from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J Immunol 190:270\u2013277. https:\/\/doi.org\/10.4049\/jimmunol.1200061","journal-title":"J Immunol"},{"key":"9066_CR119","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1016\/j.celrep.2017.03.007","volume":"18","author":"MA Sallin","year":"2017","unstructured":"Sallin MA, Sakai S, Kauffman KD et al (2017) Th1 differentiation drives the accumulation of intravascular, non-protective CD4 T cells during tuberculosis. Cell Rep 18:3091\u20133104. https:\/\/doi.org\/10.1016\/j.celrep.2017.03.007","journal-title":"Cell Rep"},{"key":"9066_CR120","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/sji.12175","volume":"79","author":"PA Bretscher","year":"2014","unstructured":"Bretscher PA (2014) On the mechanism determining the Th1\/Th2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases. Scand J Immunol 79:361\u2013376. https:\/\/doi.org\/10.1111\/sji.12175","journal-title":"Scand J Immunol"},{"key":"9066_CR121","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41541-020-00278-0","volume":"6","author":"J Li","year":"2021","unstructured":"Li J, Zhan L, Qin C (2021) The double-sided effects of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin vaccine. npj Vaccines 6:14. https:\/\/doi.org\/10.1038\/s41541-020-00278-0","journal-title":"npj Vaccines"},{"key":"9066_CR122","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.it.2016.10.009","volume":"38","author":"E Ishikawa","year":"2017","unstructured":"Ishikawa E, Mori D, Yamasaki S (2017) Recognition of mycobacterial lipids by immune receptors. Trends Immunol 38:66\u201376. https:\/\/doi.org\/10.1016\/j.it.2016.10.009","journal-title":"Trends Immunol"},{"key":"9066_CR123","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fimmu.2018.00590","volume":"9","author":"M Bermejo-Jambrina","year":"2018","unstructured":"Bermejo-Jambrina M, Eder J, Helgers LC et al (2018) C-type lectin receptors in antiviral immunity and viral escape. Front Immunol 9:590. https:\/\/doi.org\/10.3389\/fimmu.2018.00590","journal-title":"Front Immunol"},{"key":"9066_CR124","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1016\/j.csbj.2022.10.019","volume":"20","author":"S Fischer","year":"2022","unstructured":"Fischer S, Stegmann F, Gnanapragassam VS, Lepenies B (2022) From structure to function \u2013 ligand recognition by myeloid C-type lectin receptors. Comput Struct Biotechnol J 20:5790\u20135812. https:\/\/doi.org\/10.1016\/j.csbj.2022.10.019","journal-title":"Comput Struct Biotechnol J"},{"key":"9066_CR125","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nri.2016.55","volume":"16","author":"TBH Geijtenbeek","year":"2016","unstructured":"Geijtenbeek TBH, Gringhuis SI (2016) C-type lectin receptors in the control of T helper cell differentiation. Nat Rev Immunol 16:433\u2013448. https:\/\/doi.org\/10.1038\/nri.2016.55","journal-title":"Nat Rev Immunol"},{"key":"9066_CR126","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki A, Medzhitov R (2015) Control of adaptive immunity by the innate immune system. Nat Immunol 16:343\u2013353. https:\/\/doi.org\/10.1038\/ni.3123","journal-title":"Nat Immunol"},{"key":"9066_CR127","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/cmi.12249","volume":"16","author":"JC Hoving","year":"2014","unstructured":"Hoving JC, Wilson GJ, Brown GD (2014) Signalling C-type lectin receptors, microbial recognition and immunity. Cell Microbiol 16:185\u2013194. https:\/\/doi.org\/10.1111\/cmi.12249","journal-title":"Cell Microbiol"},{"key":"9066_CR128","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/s1471-4906(01)02005-1","volume":"22","author":"DM Frucht","year":"2001","unstructured":"Frucht DM, Fukao T, Bogdan C et al (2001) IFN-\u03b3 production by antigen-presenting cells: mechanisms emerge. Trends Immunol 22:556\u2013560. https:\/\/doi.org\/10.1016\/s1471-4906(01)02005-1","journal-title":"Trends Immunol"},{"key":"9066_CR129","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s1359-6101(03)00043-1","volume":"14","author":"WT Watford","year":"2003","unstructured":"Watford WT, Moriguchi M, Morinobu A, O\u2019Shea JJ (2003) The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14:361\u2013368. https:\/\/doi.org\/10.1016\/s1359-6101(03)00043-1","journal-title":"Cytokine Growth Factor Rev"},{"key":"9066_CR130","doi-asserted-by":"publisher","first-page":"925135","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4+T cells: differentiation and functions. J Immunol Res 2012:925135. https:\/\/doi.org\/10.1155\/2012\/925135","journal-title":"J Immunol Res"},{"key":"9066_CR131","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.vaccine.2008.10.053","volume":"27","author":"AE Hogg","year":"2009","unstructured":"Hogg AE, Worth A, Beverley P et al (2009) The antigen-specific memory CD8+ T-cell response induced by BCG in cattle resides in the CD8+\u03b3\/\u03b4TCR\u2212CD45RO+ T-cell population. Vaccine 27:270\u2013279. https:\/\/doi.org\/10.1016\/j.vaccine.2008.10.053","journal-title":"Vaccine"},{"key":"9066_CR132","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.4049\/jimmunol.173.7.4590","volume":"173","author":"J Wang","year":"2004","unstructured":"Wang J, Santosuosso M, Ngai P et al (2004) Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J Immunol 173:4590\u20134597. https:\/\/doi.org\/10.4049\/jimmunol.173.7.4590","journal-title":"J Immunol"},{"key":"9066_CR133","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.1038\/s41467-023-41768-8","volume":"14","author":"E Moreo","year":"2023","unstructured":"Moreo E, Jarit-Cabanillas A, Robles-Vera I et al (2023) Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung. Nat Commun 14:6090. https:\/\/doi.org\/10.1038\/s41467-023-41768-8","journal-title":"Nat Commun"},{"key":"9066_CR134","doi-asserted-by":"publisher","first-page":"104865","DOI":"10.1016\/j.cellimm.2024.104865","volume":"403","author":"M Gunasena","year":"2024","unstructured":"Gunasena M, Alles M, Demberg T et al (2024) BCG immunization induced KLRG1+ NK cells show memory-like responses to mycobacterial and HIV antigens. Cell Immunol 403:104865. https:\/\/doi.org\/10.1016\/j.cellimm.2024.104865","journal-title":"Cell Immunol"},{"key":"9066_CR135","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41585-018-0075-0","volume":"15","author":"A Fenner","year":"2018","unstructured":"Fenner A (2018) BCG enriches Treg cells. Nat Rev Urol 15:591\u2013591. https:\/\/doi.org\/10.1038\/s41585-018-0075-0","journal-title":"Nat Rev Urol"},{"key":"9066_CR136","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.1038\/s41598-021-94529-2","volume":"11","author":"RC Keefe","year":"2021","unstructured":"Keefe RC, Takahashi H, Tran L et al (2021) BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation. Sci Rep 11:14933. https:\/\/doi.org\/10.1038\/s41598-021-94529-2","journal-title":"Sci Rep"},{"key":"9066_CR137","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","volume":"10","author":"C Covi\u00e1n","year":"2019","unstructured":"Covi\u00e1n C, Fern\u00e1ndez-Fierro A, Retamal-D\u00edaz A et al (2019) BCG-induced cross-protection and development of trained immunity: implication for vaccine design. Front Immunol 10:2806. https:\/\/doi.org\/10.3389\/fimmu.2019.02806","journal-title":"Front Immunol"},{"key":"9066_CR138","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3389\/fimmu.2019.01317","volume":"10","author":"R Tanner","year":"2019","unstructured":"Tanner R, Villarreal-Ramos B, Vordermeier HM, McShane H (2019) The humoral immune response to BCG vaccination. Front Immunol 10:1317. https:\/\/doi.org\/10.3389\/fimmu.2019.01317","journal-title":"Front Immunol"},{"key":"9066_CR139","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.it.2021.12.006","volume":"43","author":"JA Soto","year":"2022","unstructured":"Soto JA, G\u00e1lvez NMS, Andrade CA et al (2022) BCG vaccination induces cross-protective immunity against pathogenic microorganisms. Trends Immunol 43:322\u2013335. https:\/\/doi.org\/10.1016\/j.it.2021.12.006","journal-title":"Trends Immunol"},{"key":"9066_CR140","doi-asserted-by":"publisher","first-page":"e148291","DOI":"10.1172\/jci148291","volume":"131","author":"AK Singh","year":"2021","unstructured":"Singh AK, Netea MG, Bishai WR (2021) BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases. J Clin Investig 131:e148291. https:\/\/doi.org\/10.1172\/jci148291","journal-title":"J Clin Investig"},{"key":"9066_CR141","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/ije\/dyac039","volume":"51","author":"O Nakken","year":"2022","unstructured":"Nakken O, Holm\u00f8y T, Stigum H et al (2022) Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study. Int J Epidemiol 51:1637\u20131644. https:\/\/doi.org\/10.1093\/ije\/dyac039","journal-title":"Int J Epidemiol"},{"key":"9066_CR142","doi-asserted-by":"publisher","first-page":"2380465","DOI":"10.1080\/08916934.2024.2380465","volume":"57","author":"VP Mora","year":"2024","unstructured":"Mora VP, Quero FB, Troncoso-Bravo T et al (2024) Partial long-term clinical improvement after a BCG challenge in systemic lupus erythematosus-prone mice. Autoimmunity 57:2380465. https:\/\/doi.org\/10.1080\/08916934.2024.2380465","journal-title":"Autoimmunity"},{"key":"9066_CR143","doi-asserted-by":"publisher","first-page":"e0276423","DOI":"10.1371\/journal.pone.0276423","volume":"18","author":"HF Dias","year":"2023","unstructured":"Dias HF, Mochizuki Y, K\u00fchtreiber WM et al (2023) Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: results of two observational studies. PLoS One 18:e0276423. https:\/\/doi.org\/10.1371\/journal.pone.0276423","journal-title":"PLoS One"},{"key":"9066_CR144","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/pathogens12040581","volume":"12","author":"P Jamshidi","year":"2023","unstructured":"Jamshidi P, Danaei B, Mohammadzadeh B et al (2023) BCG vaccination and the risk of type 1 diabetes mellitus: a systematic review and meta-analysis. Pathogens 12:581. https:\/\/doi.org\/10.3390\/pathogens12040581","journal-title":"Pathogens"},{"key":"9066_CR145","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.1016\/j.vaccine.2019.09.023","volume":"37","author":"A Rieckmann","year":"2019","unstructured":"Rieckmann A, Meyle KD, Rod NH et al (2019) Smallpox and BCG vaccination in childhood and cutaneous malignant melanoma in Danish adults followed from 18 to 49 years. Vaccine 37:6730\u20136736. https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.023","journal-title":"Vaccine"},{"key":"9066_CR146","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/joim.13037","volume":"288","author":"M Kremenovic","year":"2020","unstructured":"Kremenovic M, Schenk M, Lee DJ (2020) Clinical and molecular insights into BCG immunotherapy for melanoma. J Intern Med 288:625\u2013640. https:\/\/doi.org\/10.1111\/joim.13037","journal-title":"J Intern Med"},{"key":"9066_CR147","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.3390\/cancers14133073","volume":"14","author":"S Jiang","year":"2022","unstructured":"Jiang S, Redelman-Sidi G (2022) BCG in bladder cancer immunotherapy. Cancers 14:3073. https:\/\/doi.org\/10.3390\/cancers14133073","journal-title":"Cancers"},{"key":"9066_CR148","doi-asserted-by":"publisher","first-page":"103150","DOI":"10.1016\/j.isci.2021.103150","volume":"24","author":"GF Shpilsky","year":"2021","unstructured":"Shpilsky GF, Takahashi H, Aristarkhova A et al (2021) Bacillus Calmette-Guerin\u2019s beneficial impact on glucose metabolism: evidence for broad based applications. iScience 24:103150. https:\/\/doi.org\/10.1016\/j.isci.2021.103150","journal-title":"iScience"},{"key":"9066_CR149","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","volume":"82","author":"G Ristori","year":"2014","unstructured":"Ristori G, Romano S, Cannoni S et al (2014) Effects of Bacille Calmette-Gu\u00e9rin after the first demyelinating event in the CNS. Neurology 82:41\u201348. https:\/\/doi.org\/10.1212\/01.wnl.0000438216.93319.ab","journal-title":"Neurology"},{"key":"9066_CR150","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts RJW, Moorlag SJCFM, Novakovic B et al (2018) BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23:89-100.e5. https:\/\/doi.org\/10.1016\/j.chom.2017.12.010","journal-title":"Cell Host Microbe"},{"key":"9066_CR151","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F et al (2012) Bacille Calmette-Gu\u00e9rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci 109:17537\u201317542. https:\/\/doi.org\/10.1073\/pnas.1202870109","journal-title":"Proc Natl Acad Sci"},{"key":"9066_CR152","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","volume":"28","author":"B Cirovic","year":"2020","unstructured":"Cirovic B, de Bree LCJ, Groh L et al (2020) BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment. Cell Host Microbe 28:322-334.e5. https:\/\/doi.org\/10.1016\/j.chom.2020.05.014","journal-title":"Cell Host Microbe"},{"key":"9066_CR153","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","volume":"20","author":"LAJ O\u2019Neill","year":"2020","unstructured":"O\u2019Neill LAJ, Netea MG (2020) BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol 20:335\u2013337. https:\/\/doi.org\/10.1038\/s41577-020-0337-y","journal-title":"Nat Rev Immunol"},{"key":"9066_CR154","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","volume":"181","author":"MG Netea","year":"2020","unstructured":"Netea MG, Giamarellos-Bourboulis EJ, Dom\u00ednguez-Andr\u00e9s J et al (2020) Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell 181:969\u2013977. https:\/\/doi.org\/10.1016\/j.cell.2020.04.042","journal-title":"Cell"},{"key":"9066_CR155","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.it.2025.02.012","volume":"46","author":"L Minute","year":"2025","unstructured":"Minute L, Montalb\u00e1n-Hern\u00e1ndez K, Bravo-Robles L et al (2025) Trained immunity-based mucosal immunotherapies for the prevention of respiratory infections. Trends Immunol 46:270\u2013283. https:\/\/doi.org\/10.1016\/j.it.2025.02.012","journal-title":"Trends Immunol"},{"key":"9066_CR156","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41590-022-01354-4","volume":"23","author":"M Jeyanathan","year":"2022","unstructured":"Jeyanathan M, Vaseghi-Shanjani M, Afkhami S et al (2022) Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut\u2013lung axis. Nat Immunol 23:1687\u20131702. https:\/\/doi.org\/10.1038\/s41590-022-01354-4","journal-title":"Nat Immunol"},{"key":"9066_CR157","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jaci.2024.09.009","volume":"154","author":"L Mart\u00edn-Cruz","year":"2024","unstructured":"Mart\u00edn-Cruz L, Benito-Villalvilla C, Angelina A et al (2024) Trained immunity\u2013based vaccines for infections and allergic diseases. J Allergy Clin Immunol 154:1085\u20131094. https:\/\/doi.org\/10.1016\/j.jaci.2024.09.009","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR158","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/cea.14261","volume":"53","author":"L Mart\u00edn-Cruz","year":"2023","unstructured":"Mart\u00edn-Cruz L, Sevilla-Ortega C, Angelina A et al (2023) From trained immunity in allergy to trained immunity-based allergen vaccines. Clin Exp Allergy 53:145\u2013155. https:\/\/doi.org\/10.1111\/cea.14261","journal-title":"Clin Exp Allergy"},{"key":"9066_CR159","doi-asserted-by":"publisher","first-page":"757858","DOI":"10.3389\/fmicb.2021.757858","volume":"12","author":"E Mouhoub","year":"2021","unstructured":"Mouhoub E, Domenech P, Ndao M, Reed MB (2021) The diverse applications of recombinant BCG-based vaccines to target infectious diseases other than tuberculosis: an overview. Front Microbiol 12:757858. https:\/\/doi.org\/10.3389\/fmicb.2021.757858","journal-title":"Front Microbiol"},{"key":"9066_CR160","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1128\/cvi.00407-06","volume":"14","author":"J-S Yu","year":"2007","unstructured":"Yu J-S, Peacock JW, Jacobs WR et al (2007) Recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal Sites. Clin Vaccine Immunol 14:886\u2013893. https:\/\/doi.org\/10.1128\/cvi.00407-06","journal-title":"Clin Vaccine Immunol"},{"key":"9066_CR161","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1006\/clim.2002.5292","volume":"105","author":"M Kawahara","year":"2002","unstructured":"Kawahara M, Hashimoto A, Toida I, Honda M (2002) Oral recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity. Clin Immunol 105:326\u2013331. https:\/\/doi.org\/10.1006\/clim.2002.5292","journal-title":"Clin Immunol"},{"key":"9066_CR162","doi-asserted-by":"publisher","first-page":"15515","DOI":"10.1038\/s41598-019-51875-6","volume":"9","author":"B-J Kim","year":"2019","unstructured":"Kim B-J, Kim B-R, Kook Y-H, Kim B-J (2019) Potential of recombinant Mycobacterium paragordonae expressing HIV-1 Gag as a prime vaccine for HIV-1 infection. Sci Rep 9:15515. https:\/\/doi.org\/10.1038\/s41598-019-51875-6","journal-title":"Sci Rep"},{"key":"9066_CR163","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/v16030368","volume":"16","author":"A Kaur","year":"2024","unstructured":"Kaur A, Vaccari M (2024) Exploring HIV vaccine progress in the pre-clinical and clinical setting: from history to future prospects. Viruses 16:368. https:\/\/doi.org\/10.3390\/v16030368","journal-title":"Viruses"},{"key":"9066_CR164","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0378-1119(91)90587-2","volume":"109","author":"N Winter","year":"1991","unstructured":"Winter N, Lagranderie M, Rauzier J et al (1991) Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene 109:47\u201354. https:\/\/doi.org\/10.1016\/0378-1119(91)90587-2","journal-title":"Gene"},{"key":"9066_CR165","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1128\/jvi.71.3.2303-2309.1997","volume":"71","author":"M Lagranderie","year":"1997","unstructured":"Lagranderie M, Balazuc AM, Gicquel B, Gheorghiu M (1997) Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice. J Virol 71:2303\u20132309. https:\/\/doi.org\/10.1128\/jvi.71.3.2303-2309.1997","journal-title":"J Virol"},{"key":"9066_CR166","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fimmu.2019.00923","volume":"10","author":"A Kilpel\u00e4inen","year":"2019","unstructured":"Kilpel\u00e4inen A, Saubi N, Guitart N et al (2019) Priming with recombinant BCG expressing novel HIV-1 conserved mosaic immunogens and boosting with recombinant ChAdOx1 is safe, stable, and elicits HIV-1-specific T-cell responses in BALB\/c mice. Front Immunol 10:923. https:\/\/doi.org\/10.3389\/fimmu.2019.00923","journal-title":"Front Immunol"},{"key":"9066_CR167","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41541-020-00245-9","volume":"5","author":"R Sharan","year":"2020","unstructured":"Sharan R, Kaushal D (2020) Vaccine strategies for the Mtb\/HIV copandemic. npj Vaccines 5:95. https:\/\/doi.org\/10.1038\/s41541-020-00245-9","journal-title":"npj Vaccines"},{"key":"9066_CR168","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/157016210791208686","volume":"8","author":"R Chapman","year":"2010","unstructured":"Chapman R, Chege G, Shephard E et al (2010) Recombinant Mycobacterium bovis BCG as an HIV vaccine Vector. Curr HIV Res 8:282\u2013298. https:\/\/doi.org\/10.2174\/157016210791208686","journal-title":"Curr HIV Res"},{"key":"9066_CR169","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.chom.2016.02.012","volume":"19","author":"G Doitsh","year":"2016","unstructured":"Doitsh G, Greene WC (2016) Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe 19:280\u2013291. https:\/\/doi.org\/10.1016\/j.chom.2016.02.012","journal-title":"Cell Host Microbe"},{"key":"9066_CR170","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1084\/jem.188.5.845","volume":"188","author":"S Matsumoto","year":"1998","unstructured":"Matsumoto S, Yukitake H, Kanbara H, Yamada T (1998) Recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon \u03b3 and parasite-specific antibodies. J Exp Med 188:845\u2013854. https:\/\/doi.org\/10.1084\/jem.188.5.845","journal-title":"J Exp Med"},{"key":"9066_CR171","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.4161\/hv.28695","volume":"10","author":"D Mohamad","year":"2014","unstructured":"Mohamad D, Suppian R, Nor NM (2014) Immunomodulatory effects of recombinant BCG expressing MSP-1C of Plasmodium falciparum on LPS- or LPS+IFN-\u03b3-stimulated J774A.1 cells. Hum Vaccines Immunother 10:1880\u20131886. https:\/\/doi.org\/10.4161\/hv.28695","journal-title":"Hum Vaccines Immunother"},{"key":"9066_CR172","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.3389\/fimmu.2018.02875","volume":"9","author":"JA Soto","year":"2018","unstructured":"Soto JA, G\u00e1lvez NMS, Rivera CA et al (2018) Recombinant BCG vaccines reduce pneumovirus-caused airway pathology by inducing protective humoral immunity. Front Immunol 9:2875. https:\/\/doi.org\/10.3389\/fimmu.2018.02875","journal-title":"Front Immunol"},{"key":"9066_CR173","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.vaccine.2016.12.048","volume":"35","author":"PF C\u00e9spedes","year":"2017","unstructured":"C\u00e9spedes PF, Rey-Jurado E, Espinoza JA et al (2017) A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice. Vaccine 35:757\u2013766. https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.048","journal-title":"Vaccine"},{"key":"9066_CR174","doi-asserted-by":"publisher","first-page":"1215893","DOI":"10.3389\/fimmu.2023.1215893","volume":"14","author":"GA Pacheco","year":"2023","unstructured":"Pacheco GA, Andrade CA, G\u00e1lvez NMS et al (2023) Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults. Front Immunol 14:1215893. https:\/\/doi.org\/10.3389\/fimmu.2023.1215893","journal-title":"Front Immunol"},{"key":"9066_CR175","doi-asserted-by":"publisher","first-page":"100517","DOI":"10.1016\/j.eclinm.2020.100517","volume":"27","author":"K Abarca","year":"2020","unstructured":"Abarca K, Rey-Jurado E, Mu\u00f1oz-Durango N et al (2020) Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial. EClinicalMedicine 27:100517. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100517","journal-title":"EClinicalMedicine"},{"key":"9066_CR176","doi-asserted-by":"publisher","first-page":"664212","DOI":"10.3389\/fimmu.2021.664212","volume":"12","author":"FE D\u00edaz","year":"2021","unstructured":"D\u00edaz FE, Guerra-Maupome M, McDonald PO et al (2021) A recombinant BCG vaccine is safe and immunogenic in neonatal calves and reduces the clinical disease caused by the respiratory syncytial virus. Front Immunol 12:664212. https:\/\/doi.org\/10.3389\/fimmu.2021.664212","journal-title":"Front Immunol"},{"key":"9066_CR177","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4049\/jimmunol.1300118","volume":"192","author":"CE Palavecino","year":"2014","unstructured":"Palavecino CE, C\u00e9spedes PF, G\u00f3mez RS et al (2014) Immunization with a recombinant bacillus Calmette-Gu\u00e9rin strain confers protective Th1 immunity against the human metapneumovirus. J Immunol 192:214\u2013223. https:\/\/doi.org\/10.4049\/jimmunol.1300118","journal-title":"J Immunol"},{"key":"9066_CR178","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1128\/iai.62.6.2508-2514.1994","volume":"62","author":"MA O\u2019Donnell","year":"1994","unstructured":"O\u2019Donnell MA, Aldovini A, Duda RB et al (1994) Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun 62:2508\u20132514. https:\/\/doi.org\/10.1128\/iai.62.6.2508-2514.1994","journal-title":"Infect Immun"},{"key":"9066_CR179","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1128\/iai.63.3.799-803.1995","volume":"63","author":"D Kong","year":"1995","unstructured":"Kong D, Kunimoto DY (1995) Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG. Infect Immun 63:799\u2013803. https:\/\/doi.org\/10.1128\/iai.63.3.799-803.1995","journal-title":"Infect Immun"},{"key":"9066_CR180","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/bf02307089","volume":"2","author":"RB Duda","year":"1995","unstructured":"Duda RB, Yang H, Dooley DD, Abu-Jawdeh G (1995) Recombinant BCG therapy suppresses melanoma tumor growth. Ann Surg Oncol 2:542\u2013549. https:\/\/doi.org\/10.1007\/bf02307089","journal-title":"Ann Surg Oncol"},{"key":"9066_CR181","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3892\/etm.2017.4273","volume":"13","author":"W Liu","year":"2017","unstructured":"Liu W, Xu Y, Shen H et al (2017) Recombinant Bacille Calmette-Gu\u00e9rin coexpressing Ag85B-IFN-\u03b3 enhances the cell-mediated immunity in C57BL\/6 mice. Exp Ther Med 13:2339\u20132347. https:\/\/doi.org\/10.3892\/etm.2017.4273","journal-title":"Exp Ther Med"},{"key":"9066_CR182","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1574-695x.2007.00322.x","volume":"51","author":"Y Xu","year":"2007","unstructured":"Xu Y, Zhu B, Wang Q et al (2007) Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-\u03b3 confers effective protection against Mycobacterium tuberculosis in C57BL\/6 mice. FEMS Immunol M\u00e9d Microbiol 51:480\u2013487. https:\/\/doi.org\/10.1111\/j.1574-695x.2007.00322.x","journal-title":"FEMS Immunol M\u00e9d Microbiol"},{"key":"9066_CR183","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/eji.200939583","volume":"40","author":"BE Schneider","year":"2010","unstructured":"Schneider BE, Korbel D, Hagens K et al (2010) A role for IL-18 in protective immunity against Mycobacterium tuberculosis. Eur J Immunol 40:396\u2013405. https:\/\/doi.org\/10.1002\/eji.200939583","journal-title":"Eur J Immunol"},{"key":"9066_CR184","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2249.2004.02522.x","volume":"137","author":"Y Luo","year":"2004","unstructured":"Luo Y, Yamada H, Chen X et al (2004) Recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity. Clin Exp Immunol 137:24\u201334. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02522.x","journal-title":"Clin Exp Immunol"},{"key":"9066_CR185","doi-asserted-by":"publisher","first-page":"359153","DOI":"10.1155\/2015\/359153","volume":"2015","author":"P Szpakowski","year":"2015","unstructured":"Szpakowski P, Biet F, Locht C et al (2015) Dendritic cell activity driven by recombinant Mycobacterium bovis BCG producing human IL-18, in healthy BCG vaccinated adults. J Immunol Res 2015:359153. https:\/\/doi.org\/10.1155\/2015\/359153","journal-title":"J Immunol Res"},{"key":"9066_CR186","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1348-0421.2011.00376.x","volume":"55","author":"Y Deng","year":"2011","unstructured":"Deng Y, Bao L, Yang X (2011) Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human interleukin-12p70 and early secretory antigen target-6 fusion protein. Microbiol Immunol 55:798\u2013808. https:\/\/doi.org\/10.1111\/j.1348-0421.2011.00376.x","journal-title":"Microbiol Immunol"},{"key":"9066_CR187","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s002620050283","volume":"42","author":"T Fujimoto","year":"1996","unstructured":"Fujimoto T, O\u2019Donnell MA, Szilvasi A et al (1996) Bacillus Calmette-Gu\u00e9rin plus interleukin-2 and\/or granulocyte\/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-\u03b3, which inhibits B16F10 melanoma cell growth in vitro. Cancer Immunol, Immunother 42:280\u2013284. https:\/\/doi.org\/10.1007\/s002620050283","journal-title":"Cancer Immunol, Immunother"},{"key":"9066_CR188","doi-asserted-by":"publisher","first-page":"060","DOI":"10.1055\/s-0041-1740982","volume":"43","author":"C Cill\u00f3niz","year":"2022","unstructured":"Cill\u00f3niz C, Peric\u00e0s JM, Rojas JR, Torres A (2022) Severe infections due to respiratory viruses. Semin Respir Crit Care Med 43:060\u2013074. https:\/\/doi.org\/10.1055\/s-0041-1740982","journal-title":"Semin Respir Crit Care Med"},{"key":"9066_CR189","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3349\/ymj.2011.52.6.1008","volume":"52","author":"B-Y Jeon","year":"2011","unstructured":"Jeon B-Y, Eoh H, Ha S-J et al (2011) Co-immunization of plasmid DNA encoding IL-12 and IL-18 with bacillus Calmette-Gu\u00e9rin vaccine against progressive tuberculosis. Yonsei M\u00e9d J 52:1008\u20131015. https:\/\/doi.org\/10.3349\/ymj.2011.52.6.1008","journal-title":"Yonsei M\u00e9d J"},{"key":"9066_CR190","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/immu.200390008","volume":"33","author":"EGR Lichtenauer-Kaligis","year":"2003","unstructured":"Lichtenauer-Kaligis EGR, de Boer T, Verreck FAW et al (2003) Severe Mycobacterium bovis BCG infections in a large series of novel IL\u201312 receptor \u03b21 deficient patients and evidence for the existence of partial IL\u201312 receptor \u03b21 deficiency. Eur J Immunol 33:59\u201369. https:\/\/doi.org\/10.1002\/immu.200390008","journal-title":"Eur J Immunol"},{"key":"9066_CR191","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/s0091-6749(98)70030-2","volume":"102","author":"U Herz","year":"1998","unstructured":"Herz U, Gerhold K, Gr\u00fcber C et al (1998) BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 102:867\u2013874. https:\/\/doi.org\/10.1016\/s0091-6749(98)70030-2","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR192","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/08820130801967833","volume":"37","author":"Y Cui","year":"2008","unstructured":"Cui Y, Choi IS, Koh Y-A et al (2008) Effects of combined BCG and DHEA treatment in preventing the development of asthma. Immunol Investig 37:191\u2013202. https:\/\/doi.org\/10.1080\/08820130801967833","journal-title":"Immunol Investig"},{"key":"9066_CR193","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/all.12099","volume":"68","author":"G Zhang","year":"2013","unstructured":"Zhang G, Wang P, Qiu Z et al (2013) Distant lymph nodes serve as pools of Th1 cells induced by neonatal BCG vaccination for the prevention of asthma in mice. Allergy 68:330\u2013338. https:\/\/doi.org\/10.1111\/all.12099","journal-title":"Allergy"},{"key":"9066_CR194","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cyto.2017.09.005","volume":"99","author":"ACC Gouveia","year":"2017","unstructured":"Gouveia ACC, Braga FG, Mota M et al (2017) Enhanced expression of PD-L1 and IFN-\u03b3 on dendritic cells is associated with BCG-induced Th2 inhibition. Cytokine 99:163\u2013172. https:\/\/doi.org\/10.1016\/j.cyto.2017.09.005","journal-title":"Cytokine"},{"key":"9066_CR195","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000222673","volume":"150","author":"B Ahrens","year":"2009","unstructured":"Ahrens B, Gr\u00fcber C, Rha R-D et al (2009) BCG priming of dendritic cells enhances T regulatory and Th1 function and suppresses allergen-induced Th2 function in vitro and in vivo. Int Arch Allergy Immunol 150:210\u2013220. https:\/\/doi.org\/10.1159\/000222673","journal-title":"Int Arch Allergy Immunol"},{"key":"9066_CR196","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1046\/j.1365-2222.2003.01612.x","volume":"33","author":"C Hubeau","year":"2003","unstructured":"Hubeau C, Singer M, Lagranderie M et al (2003) Extended freeze-dried Mycobacterium bovis bacillus Calmette-Gu\u00e9rin induces the release of interleukin-12 but not tumour necrosis factor-\u03b1 by alveolar macrophages, both in vitro and in vivo. Clin Exp Allergy 33:386\u2013393. https:\/\/doi.org\/10.1046\/j.1365-2222.2003.01612.x","journal-title":"Clin Exp Allergy"},{"key":"9066_CR197","first-page":"152","volume":"35","author":"J-J Tsai","year":"2002","unstructured":"Tsai J-J, Liu Y-H, Shen H-D et al (2002) Prevention of Der p2-induced allergic airway inflammation by Mycobacterium-bacillus Calmette Guerin. J Microbiol Immunol Infect Wei mian yu gan ran za zhi 35:152\u2013158","journal-title":"J Microbiol Immunol Infect Wei mian yu gan ran za zhi"},{"key":"9066_CR198","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/s1081-1206(10)61890-x","volume":"88","author":"IS Choi","year":"2002","unstructured":"Choi IS, Koh YI (2002) Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann Allergy Asthma Immunol 88:584\u2013591. https:\/\/doi.org\/10.1016\/s1081-1206(10)61890-x","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9066_CR199","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1081\/jas-120002473","volume":"39","author":"IB Barlan","year":"2002","unstructured":"Barlan IB, T\u00fckenmez F, Bah\u00e7eciler NN, Ba\u015faran MM (2002) The impact of in vivo Calmette-Gu\u00e9rin bacillus administration on in vitro IgE secretion in atopic children. J Asthma 39:239\u2013246. https:\/\/doi.org\/10.1081\/jas-120002473","journal-title":"J Asthma"},{"key":"9066_CR200","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2222.2007.02859.x","volume":"38","author":"TJ Steenhuis","year":"2008","unstructured":"Steenhuis TJ, Aalderen WMCV, Bloksma N et al (2008) Bacille\u2013Calmette\u2013Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single-blind study. Clin Exp Allergy 38:79\u201385. https:\/\/doi.org\/10.1111\/j.1365-2222.2007.02859.x","journal-title":"Clin Exp Allergy"},{"key":"9066_CR201","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaci.2010.07.039","volume":"127","author":"DL Arnoldussen","year":"2011","unstructured":"Arnoldussen DL, Linehan M, Sheikh A (2011) BCG vaccination and allergy: a systematic review and meta-analysis. J Allergy Clin Immunol 127:246-253.e21. https:\/\/doi.org\/10.1016\/j.jaci.2010.07.039","journal-title":"J Allergy Clin Immunol"},{"key":"9066_CR202","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1111\/all.14771","volume":"76","author":"S Navaratna","year":"2021","unstructured":"Navaratna S, Estcourt MJ, Burgess J et al (2021) Childhood vaccination and allergy: a systematic review and meta-analysis. Allergy 76:2135\u20132152. https:\/\/doi.org\/10.1111\/all.14771","journal-title":"Allergy"},{"key":"9066_CR203","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/s1081-1206(10)61021-6","volume":"95","author":"IS Choi","year":"2005","unstructured":"Choi IS, Lin X-H, Koh Y-A et al (2005) Strain-dependent suppressive effects of BCG vaccination on asthmatic reactions in BALB\/c mice. Ann Allergy, Asthma Immunol 95:571\u2013578. https:\/\/doi.org\/10.1016\/s1081-1206(10)61021-6","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"9066_CR204","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","volume":"178","author":"GG Mahairas","year":"1996","unstructured":"Mahairas GG, Sabo PJ, Hickey MJ et al (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178:1274\u20131282. https:\/\/doi.org\/10.1128\/jb.178.5.1274-1282.1996","journal-title":"J Bacteriol"},{"key":"9066_CR205","doi-asserted-by":"publisher","first-page":"e71243","DOI":"10.1371\/journal.pone.0071243","volume":"8","author":"W Zhang","year":"2013","unstructured":"Zhang W, Zhang Y, Zheng H et al (2013) Genome sequencing and analysis of BCG vaccine strains. PLoS One 8:e71243. https:\/\/doi.org\/10.1371\/journal.pone.0071243","journal-title":"PLoS One"},{"key":"9066_CR206","doi-asserted-by":"publisher","first-page":"696734","DOI":"10.3389\/fimmu.2021.696734","volume":"12","author":"MH Abdelaziz","year":"2021","unstructured":"Abdelaziz MH, Ji X, Wan J et al (2021) Mycobacterium-induced Th1, helminths-induced Th2 cells and the potential vaccine candidates for allergic asthma: imitation of natural infection. Front Immunol 12:696734. https:\/\/doi.org\/10.3389\/fimmu.2021.696734","journal-title":"Front Immunol"},{"key":"9066_CR207","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/mi.2017.67","volume":"11","author":"DF Hoft","year":"2018","unstructured":"Hoft DF, Xia M, Zhang GL et al (2018) PO and ID BCG vaccination in humans induce distinct mucosal and systemic immune responses and CD4+ T cell transcriptomal molecular signatures. Mucosal Immunol 11:486\u2013495. https:\/\/doi.org\/10.1038\/mi.2017.67","journal-title":"Mucosal Immunol"},{"key":"9066_CR208","doi-asserted-by":"publisher","first-page":"103186","DOI":"10.1016\/j.ebiom.2020.103186","volume":"64","author":"R Taranc\u00f3n","year":"2021","unstructured":"Taranc\u00f3n R, Mata E, Uranga S et al (2021) Therapeutic efficacy of pulmonary live tuberculosis vaccines against established asthma by subverting local immune environment. EBioMedicine 64:103186. https:\/\/doi.org\/10.1016\/j.ebiom.2020.103186","journal-title":"EBioMedicine"},{"key":"9066_CR209","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00408-007-9003-4","volume":"185","author":"IS Choi","year":"2007","unstructured":"Choi IS, Lin X-H, Koh Y-A, Cui Y (2007) Inoculation route-dependent and allergen-specific suppressive effects of Bacille Calmette-Gu\u00e9rin vaccination on asthmatic reactions in BALB\/c mice. Lung 185:179\u2013186. https:\/\/doi.org\/10.1007\/s00408-007-9003-4","journal-title":"Lung"},{"key":"9066_CR210","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/trstmh\/tru206","volume":"109","author":"Z-RM Thomas","year":"2015","unstructured":"Thomas Z-RM, McShane H (2015) Aerosol immunisation for TB: matching route of vaccination to route of infection. Trans R Soc Trop Med Hyg 109:175\u2013181. https:\/\/doi.org\/10.1093\/trstmh\/tru206","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"9066_CR211","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/vaccines9030277","volume":"9","author":"M Kowalewicz-Kulbat","year":"2021","unstructured":"Kowalewicz-Kulbat M, Szpakowski P, Krawczyk KT et al (2021) Decrease of IL-5 production by naive T cells cocultured with IL-18-producing BCG-pulsed dendritic cells from patients allergic to house dust mite. Vaccines 9:277. https:\/\/doi.org\/10.3390\/vaccines9030277","journal-title":"Vaccines"},{"key":"9066_CR212","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.4049\/jimmunol.164.5.2701","volume":"164","author":"JS Wild","year":"2000","unstructured":"Wild JS, Sigounas A, Sur N et al (2000) IFN-\u03b3-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. J Immunol 164:2701\u20132710. https:\/\/doi.org\/10.4049\/jimmunol.164.5.2701","journal-title":"J Immunol"},{"key":"9066_CR213","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/jci5155","volume":"103","author":"G Hansen","year":"1999","unstructured":"Hansen G, Berry G, DeKruyff RH, Umetsu DT (1999) Allergen-specific Th1 cells fail to counterbalance Th2 cell\u2013induced airway hyperreactivity but cause severe airway inflammation. J Clin Investig 103:175\u2013183. https:\/\/doi.org\/10.1172\/jci5155","journal-title":"J Clin Investig"},{"key":"9066_CR214","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","volume":"38","author":"A Ray","year":"2017","unstructured":"Ray A, Kolls JK (2017) Neutrophilic inflammation in asthma and association with disease severity. Trends Immunol 38:942\u2013954. https:\/\/doi.org\/10.1016\/j.it.2017.07.003","journal-title":"Trends Immunol"},{"key":"9066_CR215","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1172\/jci80911","volume":"125","author":"M Raundhal","year":"2015","unstructured":"Raundhal M, Morse C, Khare A et al (2015) High IFN-\u03b3 and low SLPI mark severe asthma in mice and humans. J Clin Investig 125:3037\u20133050. https:\/\/doi.org\/10.1172\/jci80911","journal-title":"J Clin Investig"},{"key":"9066_CR216","doi-asserted-by":"publisher","first-page":"e94580","DOI":"10.1172\/jci.insight.94580","volume":"2","author":"M Gauthier","year":"2017","unstructured":"Gauthier M, Chakraborty K, Oriss TB et al (2017) Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias. JCI Insight 2:e94580. https:\/\/doi.org\/10.1172\/jci.insight.94580","journal-title":"JCI Insight"},{"key":"9066_CR217","doi-asserted-by":"publisher","first-page":"7549","DOI":"10.3390\/ijms23147549","volume":"23","author":"KM Garcia-Rodriguez","year":"2022","unstructured":"Garcia-Rodriguez KM, Goenka A, Thomson DD et al (2022) Bacillus Calmette\u2013Gu\u00e9rin-induced human mast cell activation relies on IL-33 priming. Int J Mol Sci 23:7549. https:\/\/doi.org\/10.3390\/ijms23147549","journal-title":"Int J Mol Sci"},{"key":"9066_CR218","doi-asserted-by":"publisher","first-page":"104380","DOI":"10.1016\/j.cellimm.2021.104380","volume":"365","author":"N Naqvi","year":"2021","unstructured":"Naqvi N, Srivastava R, Naskar P, Puri N (2021) Mast cells modulate early responses to Mycobacterium bovis bacillus Calmette-Guerin by phagocytosis and formation of extracellular traps. Cell Immunol 365:104380. https:\/\/doi.org\/10.1016\/j.cellimm.2021.104380","journal-title":"Cell Immunol"},{"key":"9066_CR219","doi-asserted-by":"publisher","first-page":"886044","DOI":"10.3389\/fimmu.2022.886044","volume":"13","author":"I Torres-Atencio","year":"2022","unstructured":"Torres-Atencio I, Campble A, Goodridge A, Martin M (2022) Uncovering the mast cell response to Mycobacterium tuberculosis. Front Immunol 13:886044. https:\/\/doi.org\/10.3389\/fimmu.2022.886044","journal-title":"Front Immunol"},{"key":"9066_CR220","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1182\/blood-2008-07-166595","volume":"113","author":"V Driss","year":"2009","unstructured":"Driss V, Legrand F, Hermann E et al (2009) TLR2-dependent eosinophil interactions with mycobacteria: role of \u03b1-defensins. Blood 113:3235\u20133244. https:\/\/doi.org\/10.1182\/blood-2008-07-166595","journal-title":"Blood"},{"key":"9066_CR221","doi-asserted-by":"publisher","first-page":"591.e9","DOI":"10.1016\/j.urology.2007.07.032","volume":"70","author":"A Hidoussi","year":"2007","unstructured":"Hidoussi A, Slama A, Jaidane M et al (2007) Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation. Urology 70:591.e9-591.e10. https:\/\/doi.org\/10.1016\/j.urology.2007.07.032","journal-title":"Urology"},{"key":"9066_CR222","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1128\/iai.68.5.2976-2978.2000","volume":"68","author":"J Kirman","year":"2000","unstructured":"Kirman J, Zakaria Z, McCoy K et al (2000) Role of eosinophils in the pathogenesis of Mycobacterium bovis BCG infection in gamma interferon receptor-deficient mice. Infect Immun 68:2976\u20132978. https:\/\/doi.org\/10.1128\/iai.68.5.2976-2978.2000","journal-title":"Infect Immun"},{"key":"9066_CR223","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/1573395054065115","volume":"1","author":"J Liu","year":"2005","unstructured":"Liu J, Cao S, Kim S et al (2005) Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression. Curr Immunol Rev 1:119\u2013137. https:\/\/doi.org\/10.2174\/1573395054065115","journal-title":"Curr Immunol Rev"},{"key":"9066_CR224","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.it.2006.11.002","volume":"28","author":"AM Cooper","year":"2007","unstructured":"Cooper AM, Khader SA (2007) IL-12p40: an inherently agonistic cytokine. Trends Immunol 28:33\u201338. https:\/\/doi.org\/10.1016\/j.it.2006.11.002","journal-title":"Trends Immunol"},{"key":"9066_CR225","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cyto.2015.01.030","volume":"75","author":"L Sun","year":"2015","unstructured":"Sun L, He C, Nair L et al (2015) Interleukin 12 (IL-12) family cytokines: role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine 75:249\u2013255. https:\/\/doi.org\/10.1016\/j.cyto.2015.01.030","journal-title":"Cytokine"},{"key":"9066_CR226","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133\u2013146. https:\/\/doi.org\/10.1038\/nri1001","journal-title":"Nat Rev Immunol"},{"key":"9066_CR227","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","volume":"13","author":"G Trinchieri","year":"1995","unstructured":"Trinchieri G (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251\u2013276. https:\/\/doi.org\/10.1146\/annurev.iy.13.040195.001343","journal-title":"Annu Rev Immunol"},{"key":"9066_CR228","doi-asserted-by":"publisher","first-page":"e13739","DOI":"10.1111\/cpr.13739","volume":"58","author":"Z Wu","year":"2025","unstructured":"Wu Z, Li W, Tan M et al (2025) IL-12 minicircle delivery via extracellular vesicles as immunotherapy for bladder cancer. Cell Prolif 58:e13739. https:\/\/doi.org\/10.1111\/cpr.13739","journal-title":"Cell Prolif"},{"key":"9066_CR229","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.4049\/jimmunol.169.12.6977","volume":"169","author":"AA Akhiani","year":"2002","unstructured":"Akhiani AA, Pappo J, Kabok Z et al (2002) Protection against Helicobacter pylori infection following immunization Is IL-12-dependent and mediated by Th1 cells. J Immunol 169:6977\u20136984. https:\/\/doi.org\/10.4049\/jimmunol.169.12.6977","journal-title":"J Immunol"},{"key":"9066_CR230","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.4049\/jimmunol.162.5.2912","volume":"162","author":"JI Sin","year":"1999","unstructured":"Sin JI, Kim JJ, Arnold RL et al (1999) IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J Immunol (Baltim, Md: 1950 ) 162:2912\u201321","journal-title":"J Immunol (Baltim, Md: 1950 )"},{"key":"9066_CR231","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-3024.1998.00131.x","volume":"20","author":"I Emery","year":"1998","unstructured":"Emery I, Leclerc C, Sengphommachanh K et al (1998) In vivo treatment with recombinant IL-12 protects C57BL\/6J mice against secondary alveolar echinococcosis. Parasite Immunol 20:81\u201391. https:\/\/doi.org\/10.1046\/j.1365-3024.1998.00131.x","journal-title":"Parasite Immunol"},{"key":"9066_CR232","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/pim.12314","volume":"38","author":"LFdC de Avila","year":"2016","unstructured":"de Avila LFdC, de Leon PMM, de Moura MQ et al (2016) Modulation of IL-12 and IFN\u03b3 by probiotic supplementation promotes protection against Toxocara canis infection in mice. Parasite Immunol 38:326\u2013330. https:\/\/doi.org\/10.1111\/pim.12314","journal-title":"Parasite Immunol"},{"key":"9066_CR233","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4049\/jimmunol.156.1.263","volume":"156","author":"JF Urban","year":"1996","unstructured":"Urban JF, Fayer R, Chen SJ et al (1996) IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol 156:263\u2013268. https:\/\/doi.org\/10.4049\/jimmunol.156.1.263","journal-title":"J Immunol"},{"key":"9066_CR234","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1084\/jem.182.5.1527","volume":"182","author":"SH Gavett","year":"1995","unstructured":"Gavett SH, O\u2019Hearn DJ, Li X et al (1995) Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182:1527\u20131536. https:\/\/doi.org\/10.1084\/jem.182.5.1527","journal-title":"J Exp Med"},{"key":"9066_CR235","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/(sici)1521-4141(199802)28:02<413::aid-immu413>3.0.co;2-1","volume":"28","author":"SP Hogan","year":"1998","unstructured":"Hogan SP, Foster PS, Tan X, Ramsay AJ (1998) Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur J Immunol 28:413\u2013423. https:\/\/doi.org\/10.1002\/(sici)1521-4141(199802)28:02%3c413::aid-immu413%3e3.0.co;2-1","journal-title":"Eur J Immunol"},{"key":"9066_CR236","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1046\/j.0954-7894.2002.01346.x","volume":"32","author":"K Kuribayashi","year":"2002","unstructured":"Kuribayashi K, Kodama T, Okamura H et al (2002) Effects of post-inhalation treatment with interleukin-12 on airway hyper-reactivity, eosinophilia and interleukin-18 receptor expression in a mouse model of asthma. Clin Exp Allergy 32:641\u2013649. https:\/\/doi.org\/10.1046\/j.0954-7894.2002.01346.x","journal-title":"Clin Exp Allergy"},{"key":"9066_CR237","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/s0140-6736(00)03497-8","volume":"356","author":"SA Bryan","year":"2000","unstructured":"Bryan SA, O\u2019Connor BJ, Matti S et al (2000) Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356:2149\u20132153. https:\/\/doi.org\/10.1016\/s0140-6736(00)03497-8","journal-title":"Lancet"},{"key":"9066_CR238","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1158\/1078-0432.ccr-07-0776","volume":"13","author":"MD Vecchio","year":"2007","unstructured":"Vecchio MD, Bajetta E, Canova S et al (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13:4677\u20134685. https:\/\/doi.org\/10.1158\/1078-0432.ccr-07-0776","journal-title":"Clin Cancer Res"},{"key":"9066_CR239","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.0954-7894.2002.01350.x","volume":"32","author":"M Rais","year":"2002","unstructured":"Rais M, Wild JS, Choudhury BK et al (2002) Interleukin-12 inhibits eosinophil differentiation from bone marrow stem cells in an interferon-\u03b3-dependent manner in a mouse model of asthma. Clin Exp Allergy 32:627\u2013632. https:\/\/doi.org\/10.1046\/j.0954-7894.2002.01350.x","journal-title":"Clin Exp Allergy"},{"key":"9066_CR240","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.pupt.2009.05.002","volume":"22","author":"S Gariboldi","year":"2009","unstructured":"Gariboldi S, Palazzo M, Zanobbio L et al (2009) Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther 22:497\u2013510. https:\/\/doi.org\/10.1016\/j.pupt.2009.05.002","journal-title":"Pulm Pharmacol Ther"},{"key":"9066_CR241","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/clim.2001.5122","volume":"101","author":"S-Y Lee","year":"2001","unstructured":"Lee S-Y, Huang C-K, Zhang T-F et al (2001) Oral administration of IL-12 suppresses anaphylactic reactions in a murine model of peanut hypersensitivity. Clin Immunol 101:220\u2013228. https:\/\/doi.org\/10.1006\/clim.2001.5122","journal-title":"Clin Immunol"},{"key":"9066_CR242","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/eji.1830230923","volume":"23","author":"F Mattner","year":"1993","unstructured":"Mattner F, Fischer S, Guckes S et al (1993) The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 23:2202\u20132208. https:\/\/doi.org\/10.1002\/eji.1830230923","journal-title":"Eur J Immunol"},{"key":"9066_CR243","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4049\/jimmunol.154.1.116","volume":"154","author":"P Ling","year":"1995","unstructured":"Ling P, Gately MK, Gubler U et al (1995) Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol (Baltim, Md: 1950) 154:116\u201327","journal-title":"J Immunol (Baltim, Md: 1950)"},{"key":"9066_CR244","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2567.2005.02257.x","volume":"117","author":"O Shimozato","year":"2006","unstructured":"Shimozato O, Ugai S, Chiyo M et al (2006) The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology 117:22\u201328. https:\/\/doi.org\/10.1111\/j.1365-2567.2005.02257.x","journal-title":"Immunology"},{"key":"9066_CR245","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/187152809787582507","volume":"8","author":"K Gee","year":"2009","unstructured":"Gee K, Guzzo C, Mat NC et al (2009) The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy-Drug Targets 8:40\u201352. https:\/\/doi.org\/10.2174\/187152809787582507","journal-title":"Inflamm Allergy-Drug Targets"},{"key":"9066_CR246","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nbt0197-35","volume":"15","author":"GJ Lieschke","year":"1997","unstructured":"Lieschke GJ, Rao PK, Gately MK, Mulligan RC (1997) Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nat Biotechnol 15:35\u201340. https:\/\/doi.org\/10.1038\/nbt0197-35","journal-title":"Nat Biotechnol"},{"key":"9066_CR247","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.4049\/jimmunol.163.8.4246","volume":"163","author":"MA O\u2019Donnell","year":"1999","unstructured":"O\u2019Donnell MA, Luo Y, Chen X et al (1999) Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Gu\u00e9rin. J Immunol (Baltim, Md: 1950) 163:4246\u201352","journal-title":"J Immunol (Baltim, Md: 1950)"},{"key":"9066_CR248","doi-asserted-by":"publisher","first-page":"196","DOI":"10.25011\/cim.v33i3.13726","volume":"33","author":"X Ke","year":"2010","unstructured":"Ke X, Huang J, Chen Q et al (2010) Protective effects of combined Mycobacterium bovis BCG and interleukin-12 vaccination on airway inflammation in a murine model of allergic asthma. Clin Investig Med 33:196\u2013202. https:\/\/doi.org\/10.25011\/cim.v33i3.13726","journal-title":"Clin Investig Med"},{"key":"9066_CR249","doi-asserted-by":"publisher","first-page":"a2052","DOI":"10.1136\/bmj.a2052","volume":"337","author":"A Hawkridge","year":"2008","unstructured":"Hawkridge A, Hatherill M, Little F et al (2008) Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial. BMJ 337:a2052. https:\/\/doi.org\/10.1136\/bmj.a2052","journal-title":"BMJ"},{"key":"9066_CR250","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1128\/cvi.00394-14","volume":"21","author":"SC Derrick","year":"2014","unstructured":"Derrick SC, Kolibab K, Yang A, Morris SL (2014) Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice. Clin Vaccine Immunol 21:1443\u20131451. https:\/\/doi.org\/10.1128\/cvi.00394-14","journal-title":"Clin Vaccine Immunol"},{"key":"9066_CR251","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/s1473-3099(24)00143-9","volume":"24","author":"I Satti","year":"2024","unstructured":"Satti I, Marshall JL, Harris SA et al (2024) Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial. Lancet Infect Dis 24:909\u2013921. https:\/\/doi.org\/10.1016\/s1473-3099(24)00143-9","journal-title":"Lancet Infect Dis"},{"key":"9066_CR252","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000340007","volume":"85","author":"S-Y Qu","year":"2012","unstructured":"Qu S-Y, Ou-Yang H-F, He Y-L et al (2012) Der p 2 recombinant Bacille Calmette-Gu\u00e9rin targets dendritic cells to inhibit allergic airway inflammation in a mouse model of asthma. Respiration 85:49\u201358. https:\/\/doi.org\/10.1159\/000340007","journal-title":"Respiration"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09066-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09066-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09066-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T09:01:54Z","timestamp":1749373314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09066-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":252,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9066"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09066-x","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"28 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}